Version 1
: Received: 13 September 2024 / Approved: 18 September 2024 / Online: 18 September 2024 (11:39:11 CEST)
How to cite:
Kaewkumnerd, N.; Ramingwong, P. The Long-Term Effects of Using Placebo in Asthma Treatments. Preprints2024, 2024091395. https://doi.org/10.20944/preprints202409.1395.v1
Kaewkumnerd, N.; Ramingwong, P. The Long-Term Effects of Using Placebo in Asthma Treatments. Preprints 2024, 2024091395. https://doi.org/10.20944/preprints202409.1395.v1
Kaewkumnerd, N.; Ramingwong, P. The Long-Term Effects of Using Placebo in Asthma Treatments. Preprints2024, 2024091395. https://doi.org/10.20944/preprints202409.1395.v1
APA Style
Kaewkumnerd, N., & Ramingwong, P. (2024). The Long-Term Effects of Using Placebo in Asthma Treatments. Preprints. https://doi.org/10.20944/preprints202409.1395.v1
Chicago/Turabian Style
Kaewkumnerd, N. and Pirada Ramingwong. 2024 "The Long-Term Effects of Using Placebo in Asthma Treatments" Preprints. https://doi.org/10.20944/preprints202409.1395.v1
Abstract
Asthma is a chronic respiratory disease characterized by hyperreactivity in the airways, which can lead to significant lung damage if not properly managed. While placebos—medications with no active therapeutic ingredients—are sometimes used in clinical trials to gauge the effectiveness of asthma treatments, their long-term use raises concerns. Placebos work primarily through psychological mechanisms by enhancing patients’ expectations of treatment. However, prolonged reliance on placebo treatment in asthma could potentially mask symptoms, delay proper management, and lead to undetected lung damage or other adverse effects. This study explores the potential risks and consequences associated with long-term placebo use in asthma management.
Medicine and Pharmacology, Pulmonary and Respiratory Medicine
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
